649 related articles for article (PubMed ID: 34474013)
1. Antipsychotic use and risk of breast cancer in women with schizophrenia: a nationwide nested case-control study in Finland.
Taipale H; Solmi M; Lähteenvuo M; Tanskanen A; Correll CU; Tiihonen J
Lancet Psychiatry; 2021 Oct; 8(10):883-891. PubMed ID: 34474013
[TBL] [Abstract][Full Text] [Related]
2. Antipsychotic Use and Risk of Low-Energy Fractures in People With Schizophrenia: A Nationwide Nested Case-Control Study in Finland.
Solmi M; Lähteenvuo M; Correll CU; Tanskanen A; Tiihonen J; Taipale H
Schizophr Bull; 2023 Jan; 49(1):78-89. PubMed ID: 36334051
[TBL] [Abstract][Full Text] [Related]
3. Long-term treatment with clozapine and other antipsychotic drugs and the risk of haematological malignancies in people with schizophrenia: a nationwide case-control and cohort study in Finland.
Tiihonen J; Tanskanen A; Bell JS; Dawson JL; Kataja V; Taipale H
Lancet Psychiatry; 2022 May; 9(5):353-362. PubMed ID: 35334224
[TBL] [Abstract][Full Text] [Related]
4. Understanding the Limitations of the Odds Ratio in a Case-Control Study of the Association Between Breast Cancer and Exposure to Antipsychotic Drugs.
Andrade C
J Clin Psychiatry; 2021 Nov; 82(6):. PubMed ID: 34813689
[TBL] [Abstract][Full Text] [Related]
5. Antipsychotic exposure and type 2 diabetes among patients with schizophrenia: a matched case-control study of California Medicaid claims.
Lambert BL; Chou CH; Chang KY; Tafesse E; Carson W
Pharmacoepidemiol Drug Saf; 2005 Jun; 14(6):417-25. PubMed ID: 15786516
[TBL] [Abstract][Full Text] [Related]
6. Antipsychotic Use and Risk of Breast Cancer in Women With Severe Mental Illness: Replication of a Nationwide Nested Case-Control Database Study.
Solmi M; Lähteenvuo M; Tanskanen A; Corbeil O; Mittendorfer-Rutz E; Correll CU; Tiihonen J; Taipale H
Schizophr Bull; 2024 Apr; ():. PubMed ID: 38687213
[TBL] [Abstract][Full Text] [Related]
7. Association between long-term use of prolactin-elevating antipsychotics in women and the risk of breast cancer: What are the clinical implications?
Hope JD; Keks NA; Copolov DL
Australas Psychiatry; 2023 Apr; 31(2):205-208. PubMed ID: 36927059
[TBL] [Abstract][Full Text] [Related]
8. 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study).
Tiihonen J; Lönnqvist J; Wahlbeck K; Klaukka T; Niskanen L; Tanskanen A; Haukka J
Lancet; 2009 Aug; 374(9690):620-7. PubMed ID: 19595447
[TBL] [Abstract][Full Text] [Related]
9. Effects of antipsychotics on bone mineral density and prolactin levels in patients with schizophrenia: a 12-month prospective study.
Wang M; Hou R; Jian J; Mi G; Qiu H; Cao B; Tang M
Hum Psychopharmacol; 2014 Mar; 29(2):183-9. PubMed ID: 24738111
[TBL] [Abstract][Full Text] [Related]
10. Quetiapine versus other atypical antipsychotics for schizophrenia.
Asmal L; Flegar SJ; Wang J; Rummel-Kluge C; Komossa K; Leucht S
Cochrane Database Syst Rev; 2013 Nov; (11):CD006625. PubMed ID: 24249315
[TBL] [Abstract][Full Text] [Related]
11. Use of antipsychotics and risk of breast cancer: a Danish nationwide case-control study.
Pottegård A; Lash TL; Cronin-Fenton D; Ahern TP; Damkier P
Br J Clin Pharmacol; 2018 Sep; 84(9):2152-2161. PubMed ID: 29858518
[TBL] [Abstract][Full Text] [Related]
12. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
Krzystanek M; Krupka-Matuszczyk I
Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
[TBL] [Abstract][Full Text] [Related]
13. Antipsychotic Treatment Duration in Children and Adolescents: A Register-Based Nationwide Study.
Varimo E; Aronen ET; Mogk H; Rättö H; Saastamoinen LK
J Child Adolesc Psychopharmacol; 2021 Aug; 31(6):421-429. PubMed ID: 33739863
[No Abstract] [Full Text] [Related]
14. Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management.
Haddad PM; Wieck A
Drugs; 2004; 64(20):2291-314. PubMed ID: 15456328
[TBL] [Abstract][Full Text] [Related]
15. Effects of aripiprazole, quetiapine and ziprasidone on plasma prolactin levels in individuals with first episode nonaffective psychosis: Analysis of a randomized open-label 1year study.
Crespo-Facorro B; Ortiz-Garcia de la Foz V; Suarez-Pinilla P; Valdizan EM; Pérez-Iglesias R; Amado-Señaris JA; Teresa Garcia-Unzueta M; Labad J; Correll C; Ayesa-Arriola R
Schizophr Res; 2017 Nov; 189():134-141. PubMed ID: 28223031
[TBL] [Abstract][Full Text] [Related]
16. Relationship between antipsychotic medication treatment and new cases of diabetes among psychiatric inpatients.
Citrome L; Jaffe A; Levine J; Allingham B; Robinson J
Psychiatr Serv; 2004 Sep; 55(9):1006-13. PubMed ID: 15345760
[TBL] [Abstract][Full Text] [Related]
17. Clozapine protects bone mineral density in female patients with schizophrenia.
Lin CH; Huang KH; Chang YC; Huang YC; Hsu WC; Lin CY; Huang-Chih Chou F; Tsai GE; Lane HY
Int J Neuropsychopharmacol; 2012 Aug; 15(7):897-906. PubMed ID: 22014454
[TBL] [Abstract][Full Text] [Related]
18. Association between antipsychotic treatment and hyperlipidemia among California Medicaid patients with schizophrenia.
Lambert BL; Chang KY; Tafesse E; Carson W
J Clin Psychopharmacol; 2005 Feb; 25(1):12-8. PubMed ID: 15643095
[TBL] [Abstract][Full Text] [Related]
19. Prolactin-Elevating Antipsychotics and the Risk of Endometrial Cancer.
Klil-Drori AJ; Yin H; Abenhaim HA; du Fort GG; Azoulay L
J Clin Psychiatry; 2017 Jun; 78(6):714-719. PubMed ID: 28199787
[TBL] [Abstract][Full Text] [Related]
20. Second-generation antipsychotic medications and risk of pneumonia in schizophrenia.
Kuo CJ; Yang SY; Liao YT; Chen WJ; Lee WC; Shau WY; Chang YT; Tsai SY; Chen CC
Schizophr Bull; 2013 May; 39(3):648-57. PubMed ID: 22282455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]